Abstract:Mutations in APP leading to the development of Familial Alzheimer's Disease (FAD) has been well established, however, the normal functional role of this protein within the neuron has proven elusive. We are using the model organism Caenorhabditis elegans to investigate the pathophysiology of APP. This system is relevant to the mammalian system as both APP and key synaptic transmission pathways are highly conserved. C. elegans are particularly attractive for the study of APP because the amyloid precursor-like protein 1 (apl-1) is the only homolog of APP in the worm, while mammals contain two others, APLP1 and APLP2. The genetic redundancies from the APP homologs make analysis of APP function in mice challenging, however, in worms null mutation in the apl-1 gene leads to a lethal larval arrest, allowing direct assessment of the apl-1/APP structure and function by genetic rescue. In addition to physiological investigation, C. elegans also offer distinct advantages to study neuronal and aging pathways relevant to AD pathogenesis. To investigate the role of apl-1/APP in the regulation of cholinergic neurotransmission RNAi knockdown of apl-1 was performed followed by drug testing on the acetylcholine esterase inhibitor aldicarb. Classical epistasis experiments were performed to determine where apl-1 operates in synaptic transmission. In addition, we created transgenic worms expressing human APPC99 in neurons in order to generate a model with which to study the pathogenesis of Aβ. Consistent with an essential role for APP family of proteins in the regulation of cholinergic neurotransmission in the mouse neuromuscular junction, we show that RNAi knockdown of apl-1 leads to hypersensitivity to aldicarb. Through epistasis we have found that apl-1 operates after the action of the synaptic vesicle docking protein unc-18. In worms expressing APPC99, genetic crosses reveal that trafficking of this molecule is kinesin-dependent. Loss of apl-1/APP leads to excessive secretion of acetylcholine. apl-1/APP acts at the pre-synaptic compartment after the vesicle docking stage of synaptic vesicle exocytosis. Currently, we are performing structural/functional studies to map the domains required for apl-1/APP function as well as evaluating the processing of APPC99, Aβ pathology and effects of aging on pathology.

P1–395: the Function of Amyloid Precursor Protein (APP) in Cholinergic System

Amyolid Precursor Protein Mediates Presynaptic Localization and Activity of the High-Affinity Choline Transporter

Deciphering the Role of APP in Synaptic Function

Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2.

Functions of Amyloid Precursor Protein in Metabolic Diseases

P1-091: Investigation of APP Pathophysiology in C. Elegans

The amyloid precursor protein: beyond amyloid

Role of APP and Aβ in Synaptic Physiology.

The Amyloid Precursor Protein Modulates the Position and Length of the Axon Initial Segment

Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2.

Physiological functions of APP family proteins.

Loss of Cholinergic and Monoaminergic Afferents in APPswe/PS1ΔE9 Transgenic Mouse Model of Cerebral Amyloidosis Preferentially Occurs near Amyloid Plaques

Genetic Dissection of the Amyloid Precursor Protein in Developmental Function and Amyloid Pathogenesis

Role of APP in Neuronal Function

APP Physiological and Pathophysiological Functions: Insights from Animal Models

Regulation of Neurotransmitter Release by Amyloid Precursor Protein Through Synapsin Phosphorylation

The Role of APP in Alzheimer’s Disease

The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease.

Discrepancy of synaptic and microtubular protein phosphorylation in the hippocampus of APP/PS1 and MAPT×P301S transgenic mice at the early stage of Alzheimer's disease

Tyr682 in the Aβ-precursor protein intracellular domain regulates synaptic connectivity, cholinergic function, and cognitive performance.

Overexpression of wild-type human amyloid precursor protein alters GABAergic transmission